Review



primary antibodies against pigr  (ABclonal Biotechnology)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ABclonal Biotechnology primary antibodies against pigr
    Primary Antibodies Against Pigr, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against pigr/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against pigr - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    primary antibodies against pigr  (R&D Systems)
    91
    R&D Systems primary antibodies against pigr
    Surface Biolayer Interferometry-based binding of mAbs and bifunctional molecules to spike glycoprotein and to <t>pIgR</t> <t>.</t> <t>Antibodies</t> and antigens are indicated in the graphs. Graphs represent magnitude of response (nm) over time. Association and dissociation are displayed along with fitted curves
    Primary Antibodies Against Pigr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against pigr/product/R&D Systems
    Average 91 stars, based on 1 article reviews
    primary antibodies against pigr - by Bioz Stars, 2026-02
    91/100 stars
    		  Buy from Supplier
    primary antibodies against pigr  (ABclonal Biotechnology)
    90
    ABclonal Biotechnology primary antibodies against pigr
    Surface Biolayer Interferometry-based binding of mAbs and bifunctional molecules to spike glycoprotein and to <t>pIgR</t> <t>.</t> <t>Antibodies</t> and antigens are indicated in the graphs. Graphs represent magnitude of response (nm) over time. Association and dissociation are displayed along with fitted curves
    Primary Antibodies Against Pigr, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against pigr/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against pigr - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Surface Biolayer Interferometry-based binding of mAbs and bifunctional molecules to spike glycoprotein and to pIgR . Antibodies and antigens are indicated in the graphs. Graphs represent magnitude of response (nm) over time. Association and dissociation are displayed along with fitted curves

    Journal: mAbs

    Article Title: Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

    doi: 10.1080/19420862.2021.1987180

    Figure Lengend Snippet: Surface Biolayer Interferometry-based binding of mAbs and bifunctional molecules to spike glycoprotein and to pIgR . Antibodies and antigens are indicated in the graphs. Graphs represent magnitude of response (nm) over time. Association and dissociation are displayed along with fitted curves

    Article Snippet: Primary antibodies against pIgR (R&D Systems, MAB27171) and VHH domains (Genscript, A01995) were diluted to 5 mg/mL final concentration in PBST supplemented with 10% FBS and 500 mL was applied to the apical and basolateral chamber for 2 h at room temperature.

    Techniques: Binding Assay

    Bifunctional molecules Display Specific Functional Activity Against SARS-CoV-2 . (a) Functional competition ability is plotted vs. antibody concentration. Antibodies are indicated in the graph. (b) PBMC-mediated ADCC of MDCK-pIgR cells is plotted as green area per well (normalized to 0 h) vs concentration of bifunctional molecule (nM). Antibodies are indicated in the legend

    Journal: mAbs

    Article Title: Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

    doi: 10.1080/19420862.2021.1987180

    Figure Lengend Snippet: Bifunctional molecules Display Specific Functional Activity Against SARS-CoV-2 . (a) Functional competition ability is plotted vs. antibody concentration. Antibodies are indicated in the graph. (b) PBMC-mediated ADCC of MDCK-pIgR cells is plotted as green area per well (normalized to 0 h) vs concentration of bifunctional molecule (nM). Antibodies are indicated in the legend

    Article Snippet: Primary antibodies against pIgR (R&D Systems, MAB27171) and VHH domains (Genscript, A01995) were diluted to 5 mg/mL final concentration in PBST supplemented with 10% FBS and 500 mL was applied to the apical and basolateral chamber for 2 h at room temperature.

    Techniques: Functional Assay, Activity Assay, Concentration Assay

    Transcytosis in lung microtissues . A) Transcytosis of bifunctional molecules in EpiAirway tissue model in 24 h post application. For each sample, 20 mg of protein was added to the basolateral well, and after 24 hr, the mucosal surface was washed and the levels of transcytosed antibodies were quantified. Levels are shown in total micrograms transcytosed in a 24 h period. Error bars represent standard error and are representative of at least 2 independent experiments. B-C) Confocal image showing the human EpiAirway microtissue for CV19B307 (b) and CV19B290 (c). Staining shows: blue (nuclei), green (anti-VHH), and red (pIgR). Scale bars shows 50 mm (insets) and 100 mm (main image)

    Journal: mAbs

    Article Title: Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

    doi: 10.1080/19420862.2021.1987180

    Figure Lengend Snippet: Transcytosis in lung microtissues . A) Transcytosis of bifunctional molecules in EpiAirway tissue model in 24 h post application. For each sample, 20 mg of protein was added to the basolateral well, and after 24 hr, the mucosal surface was washed and the levels of transcytosed antibodies were quantified. Levels are shown in total micrograms transcytosed in a 24 h period. Error bars represent standard error and are representative of at least 2 independent experiments. B-C) Confocal image showing the human EpiAirway microtissue for CV19B307 (b) and CV19B290 (c). Staining shows: blue (nuclei), green (anti-VHH), and red (pIgR). Scale bars shows 50 mm (insets) and 100 mm (main image)

    Article Snippet: Primary antibodies against pIgR (R&D Systems, MAB27171) and VHH domains (Genscript, A01995) were diluted to 5 mg/mL final concentration in PBST supplemented with 10% FBS and 500 mL was applied to the apical and basolateral chamber for 2 h at room temperature.

    Techniques: Staining